Prevalence of increased fdg pet/ct axillary lymph node uptake beyond 6 weeks after mrna covid-19 vaccination

69Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study shows that avid axillary lymph node uptake at FDG PET/CT can be detected in more than a quarter of our patient population even beyond 6 weeks after the second dose of the mRNA-based COVID-19 vaccination. Compared with a previous study showing normalization of FDG uptake within 40 days of receiving an inactivated H1N1 influenza vaccine (6), we found uptake persistence even at 70 days. Physicians should be aware of this potential pitfall.

Cite

CITATION STYLE

APA

Eshet, Y., Tau, N., Alhoubani, Y., Kanana, N., Domachevsky, L., & Eifer, M. (2021). Prevalence of increased fdg pet/ct axillary lymph node uptake beyond 6 weeks after mrna covid-19 vaccination. Radiology, 300(3), E345–E347. https://doi.org/10.1148/radiol.2021210886

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free